Table 2 Statistical comparison of mean baseline cytokine levels quantified by ELISA between patients presenting clinical benefit or progression

From: Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

Cytokines

Clinical benefit (mean±s.d)

Progression (mean±s.d.)

P- value

TNF- α (pg ml−1)

76.94±194.73

164.07±134.80

0.009

MMP-9 (ng ml−1)

2972.31±1337.31

4227.3±933.73

0.027

ICAM-1 (ng ml−1)

445.7±103.77

482.2±157.99

0.900

VEGF (ng ml−1)

19.57±17.85

14.27±4.38

0.382

SDF-1 (pg ml−1)

49.17±32.87

61.86±29.33

0.371

BDNF (ng ml−1)

16.67±8.64

13.61±6.11

0.378

  1. Bold values are statistically significant.
Back to article page